According to a report by Intel Market Research, the global cancer treatment drugs market was valued at USD 193.12 billion in 2024 and is projected to grow from USD 211.45 billion in 2025 to USD 359.83 billion by 2032, exhibiting a CAGR of 9.5% during the forecast period. The market is witnessing strong growth due to the rising global burden of cancer, increasing adoption of targeted therapies...

The global imatinib drug market continues to play a crucial role in the oncology sector due to the widespread use of imatinib in targeted cancer therapies. As one of the pioneering tyrosine kinase inhibitors, imatinib has significantly transformed the treatment landscape for specific cancers by offering targeted therapeutic benefits. The drug remains an important treatment option in various...

According to a newly published market research report by 24LifeSciences, the global medical sterility testing isolators market was valued at USD 382.5 million in 2024 and is projected to reach USD 685.3 million by 2032, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2025–2032. Medical sterility testing isolators are advanced containment systems...

According to a newly published market research report by 24LifeSciences, the global medical sterility testing isolators market was valued at USD 382.5 million in 2024 and is projected to reach USD 685.3 million by 2032, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2025–2032. Medical sterility testing isolators are advanced containment systems...